---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-122574"
form_type: "8-K"
ticker: "BPTH"
cik: "0001133818"
company_name: "BIO-PATH HOLDINGS, INC."
filed_at: "2024-11-25T23:59:59+00:00"
generated_at: "2026-05-29T18:38:33.728739+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nasdaq panel grants Bio-Path continued listing subject to $2.5M equity compliance by Jan 31, 2025

## Summary
- Company must demonstrate minimum $2.5M stockholders' equity by Jan 31, 2025 to remain listed.
- If conditions not met, Bio-Path may face delisting from Nasdaq Capital Market.
- Company previously received deficiency notice in March 2024, extension in June 2024, and delisting determination in September 2024.
- Bio-Path intends to pursue compliance but cautions there is no assurance of success.

## SEC filing metadata
- accession: 0001104659-24-122574
- form_type: 8-K
- ticker: BPTH
- cik: 0001133818
- company_name: BIO-PATH HOLDINGS, INC.
- filed_at: 2024-11-25T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133818/000110465924122574/0001104659-24-122574-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133818/000110465924122574/tm2429498d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-122574
- JSON: https://secwatch.observer/filing/0001104659-24-122574.json
- Plain text: https://secwatch.observer/filing/0001104659-24-122574.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.